Meet the directors 

The names of our Trust board members are detailed below, together with a declaration of their relevant interests.

Non-executive directors
Richard Murley

Richard Murley, chairman

Richard Murley was appointed as Chairman of UCLH in July 2010 having previously served as a non-executive director. Richard was reappointed for a further three years in 2013, for 12 months in 2016, and a further 6 months up to 31 December 2017. Richard is a qualified solicitor and has worked in the City of London for more than 30 years. He is a Vice-Chairman of Rothschild where he has worked since 2006. Between 2003 and 2005, he was Director General of the Panel on Takeovers and Mergers, regulating the conduct of takeovers of public companies in the UK. Richard is also a trustee for Crisis and Macmillan Cancer Support, a co-opted trustee for the Royal Society of Medicine, a member of the Medical Research Council and Chairman of the United Trust Bank. As well as chairing the Board, Richard chairs the remuneration committee and attends the finance and contracting, investment, and quality and safety committees.
 
Declaration of interests:
  • Co-opted Trustee, Royal Society of Medicine 1.1.17-31.12.19
  • Executive vice-chairman, global Financial Advisory, NM Rothschild & Sons Limited
  • Trustee, Crisis
  • Board member, UCLPartners
  • Chairman, United Trust Bank.

back to top


Dr Harry Bush CB

Dr Harry Bush CB, non-executive director (vice chairman)

Harry Bush joined the Board in February 2012; he was reappointed for a further three years in 2016 and for an additional 12 months from February 2018. He has extensive senior management experience at HM Treasury and in the economic regulation of the aviation industry. He was most recently a member of the Civil Aviation Authority Board with executive responsibility for its economic output. Prior to that, he held a number of senior posts at HM Treasury during a long career there. Harry was appointed vice-chair in March 2013. Harry chairs the finance and contracting committee and is a member of audit, investment, and remuneration committees.

Declaration of interests:

  • Director, Directgreen Property Management Ltd
  • Director, H2B2 Ltd
  • Non-executive director, The Airline Group Ltd
  • Non-executive director, NATS Holdings Ltd.
  • Director, NATS Employee Sharetrust Ltd
  • Part-time advisory consultant, KPMG.

back to top


Althea Efunshile

Althea Efunshile CBE, non-executive director

Althea Efunshile was appointed as a non-executive director in May 2016. She has had a 30-year career in local and central government, during which she gained extensive senior management experience. She was Deputy Chief Executive of Arts Council England where she was responsible for the national investment strategy, corporate governance and operational delivery. Prior to that she held a number of director level posts within the Department for Education all of which were concerned with improving outcomes for disadvantaged children and young people. She has been the Executive Director for Education and Culture in the London Borough of Lewisham, and Assistant Director of Education in the London Borough of Merton. Althea was awarded a CBE for services to art and culture in the 2016 Queen’s birthday honours. Althea is a member of the audit, remuneration and workforce committees. She also chairs the Trust’s patient experience committee and attends the quality and safety committee.
 
Althea was awarded a CBE for services to art and culture in the 2016 Queen’s birthday honours.
 
Declaration of interests:
  • Board member, Goldsmiths College, University of London
  • Chair of the National College for Cultural and Creative Industries

back to top


David Lomas

Prof David Lomas, non-executive director

David Lomas joined the Board in September 2015. He is UCL Vice-Provost (Health), Head of the UCL School of Life and Medical Sciences, head of UCL Medical School, Academic Director of the UCLP Academic Health Sciences Centre and works as a respiratory physician at UCLH. He received his medical degree from the University of Nottingham and undertook his PhD at Trinity College, Cambridge. He was a Medical Research Council (MRC) clinician scientist, university lecturer and Professor of Respiratory Biology in Cambridge before moving to UCL in 2013 to be Chair of Medicine and Dean of the Faculty of Medical Sciences. He is Deputy Chief Executive at the Medical Research Council and previously chaired the Respiratory Therapy Area Unit Board at GlaxoSmithKline. He is also a senior investigator for the National Institute for Health Research (NIHR). David chairs the UCLH quality and safety committee and is a member of the remuneration committee.

Declaration of interests: 

  • Deputy Chief Executive of the Medical Research Council 1.1.17-31.3.18
  • Medical Trustee of the British Heart Foundation from 1.11.16
  • President of the Association of Physicians of Great Britain and Ireland, 2017-18
  • UCL Stakeholder representative on Imanova Board
  • UCL representative and Director of the KwaZulu Natal Research Institute for TB-HIV (K-RITH) Grants Advisory Committee
  • Patron, Alpha1 Awareness UK
  • Honorary Senior Treasurer, National Student Association of Medical Research
  • Scientific Advisory Committee, Genomics England
  • Chair, UK Respiratory Research Collaborative
  • GSK COPD Disease Model Steering Group
  • Member, Expert Advisory Group, Innovative Medicines and MedTech Review for the Minister of Life Sciences.
  • Founders Board, Francis Crick Institute
  • Board member, UCLPartners
  • Director, GMEC Management Company Ltd

back to top


Dr Rima Makarem

Dr Rima Makarem, non-executive director

Rima Makarem joined the Board in July 2013 as a non-executive director and was appointed as chair of the audit committee in 2014. She was reappointed for a further three years to 31 December 2019. Rima has extensive experience in healthcare and the pharmaceutical industry. She currently runs her own interim management and consultancy business and holds a portfolio of non-executive positions. Rima has significant experience as an audit chair. She was previously audit chair at NHS London and NHS Haringey before that, and is currently audit chair of the National Institute for Health and Care Excellence. Previously, Rima was Director of Competitive Excellence at GlaxoSmithKline and prior to that, a management consultant. Rima holds a PhD in biochemistry and an MBA from INSEAD Business School. Rima is a member of the remuneration committee.

Declaration of interests:
  • Director and owner, Healthpeak Limited
  • Non-executive director, Anchor Trust
  • Trustee, UCLH Charity
  • Chair, National Travel Health Network and Centre
  • Independent Member of Council at St. George’s, University of London.
  • Audit Chair, National Institute for Health & Care Excellence (NICE)

back to top


Kieran Murphy

Kieran Murphy, non-executive director

Kieran Murphy was appointed ias a non-executive director in January 2014 and reappointed for three further years in January 2017. He graduated from Cambridge and began his career as a civil servant at HM Treasury. Subsequently he joined Kleinwort Benson where he spent 15 years as a senior corporate finance adviser, culminating in leadership of the worldwide industrial sector investment banking business. Kieran joined the corporate finance advisory firm Gleacher Shacklock as a partner in 2004. He became a senior adviser prior to his retirement from the firm in December 2015. He has developed an extensive career as a board member and chairman in both the public and private sectors. He is currently chairman at Ordnance Survey, and a non-executive director at the University of London and at Aliaxis SA. He has also been a board member at City, University of London. Kieran chairs the investment committee and is a member of the finance and contracting, quality and safety and remuneration committees.

Declaration of interests:

  • Board member, City University
  • Board member, University of London
  • Non-executive director, Aliaxis S.A.
  • Chairman, Ordnance Survey.

back to top


Dr Diana Walford CBE

Dr Diana Walford CBE, non-executive director

Diana Walford joined the Board in December 2011 and was reappointed for a further three years until December 2017. She has a distinguished record at the highest level in the civil service, NHS and higher education. During her career she served the NHS as Deputy Chief Medical Officer for England, director of healthcare for the NHS Management Executive, Director of the Public Health Laboratory Service and non-executive director of the NHS Blood and Transplant Authority. Diana is also a qualified haematologist and epidemiologist and was an honorary consultant haematologist at the Central Middlesex Hospital. Most recently, she was the Principal of Mansfield College, Oxford University. Diana is a member of the audit, quality and safety, and remuneration committees.

Declaration of interests:

  • Chair of the Board of Trustees, Regent’s University London
  • Deputy chairman, Council of the London School of Hygiene and Tropical Medicine
  • Trustee, Sue Ryder.

back to top


Mr Caspar Woolley

Caspar Woolley, non-executive director

Caspar Woolley joined UCLH as a non-executive director in January 2015 and was reappointed for a second term until January 2020. Caspar is a Cambridge University graduate who started his career as a design engineer. He founded and is a Board member at Hailo Network Ltd, the taxi app. He also served as the Chief Executive Officer of E-Courier (UK) Ltd and led the eCourier.co.uk management team. He was also Vice President for Fleet at Avis. Previously, he served as the Head of Business Development for The John Lewis Partnership. He served as Vice President of Operations at buy.com (UK) Ltd. He has been an independent non-executive director of GAME Digital plc since 16 May 2014. He has also been a governor at a foundation trust. Caspar chairs the workforce committee and is a member of the finance and contracting, investment, and remuneration committees.
 
Declaration of interests:
  • Non-Executive Director, GAME Digital plc
  • Board member, Hailo Network Ltd and subsidiaries
  • Director, BeautySorted Ltd.

back to top


Executive directors
Marcel Levi

Professor Marcel Levi, chief executive

Marcel joined UCLH as chief executive in January 2017. Marcel has had a distinguished career as a clinician, academic, educator and clinical leader. Prior to joining UCLH he was chairman of the executive board of the Academic Medical Center, University of Amsterdam, for six years and before that, he was chairman of its Department of Medicine and Division of Medical Specialisms for ten years. Marcel is a practising consultant physician at UCLH, specialising in haemostasis, thrombosis and vascular medicine. He was named the best specialist in internal medicine in the Netherlands for three consecutive years. Marcel obtained his PhD in 1991 and was appointed a Fellow by the Royal Netherlands Academy of Science. He continues to lead an active research programme and has had more than 500 research papers published in international journals. Marcel was named Dutchman of the Year 2016 by a leading magazine in the Netherlands in recognition of his professional success.

back to top


Prof Geoff Bellingan

Professor Geoff Bellingan, medical director, surgery and cancer board

Geoff Bellingan was appointed Medical Director in September 2009. He previously held posts as Clinical Director and Divisional Clinical Director between 2006 and 2009. He trained as a chest physician and then in intensive care in which he has been a consultant at UCLH since 1997. He was appointed as a professor in intensive care medicine at UCL in 2015. As Medical Director for Surgery and Cancer, Geoff has a particular interest in cancer care across North and East London and West Essex, working closely with London Cancer, Macmillan and a number of other major partners. This led to the successful UCLH Cancer Collaborative application and the award of the national Cancer Vanguard in partnership with Greater Manchester Cancer Vanguard Innovation and Royal Marsden Partners. Geoff is also the senior responsible officer for the development which incorporates one of the UK’s first two NHS Proton Beam Therapy units, and a short stay surgical centre.


Declaration of interests:
  • Co-director, London Intensive Care Ltd
  • Board member, London Cancer
  • Board member, London Clinical Senate
  • Member, Adult Critical Care Clinical Reference Group
  • Member of Medical Advisory Committee, London Clinic
  • Member, Patient Safety Committee, Royal College of Physicians
  • Member, Medical Equivalence Committee, Faculty of Intensive Care Medicine.

back to top


Dr Gill Gaskin

Dr Gill Gaskin, medical director, specialist hospitals board

Gill Gaskin was appointed Medical Director of the Specialist Hospitals Board in January 2010. Gill graduated from Cambridge and trained in renal and general medicine at Hammersmith Hospital and the Royal Postgraduate Medical School, completing a PhD on the biology of systemic vasculitis. Between 1995 and 2010 she held consultant-level posts at Imperial College, Hammersmith Hospitals and Imperial College Healthcare Trusts, with additional responsibilities as Director of Postgraduate Medical Education and Professional Development, Clinical Director and latterly Director for the Medicine Clinical Programme Group. Gill is a member of the Faculty of Medical Leadership and Management.


Declaration of interests:
  • Honorary consultant, Imperial College Healthcare NHS Trust

back to top


Neil Griffiths

Neil Griffiths, deputy chief executive

Neil Griffiths joined the Board as Deputy Chief Executive in June 2014. Neil has more than 20 years’ hospital experience having joined the NHS from Bristol University in 1992. He has a background in operational, commercial and strategic management having previously worked at Lewisham, St Mary’s (now part of Imperial), East Kent, and the Royal National Orthopaedic Hospitals. Neil also previously worked at UCLH between 2003 and 2008. Before his current post Neil spent six years working in the private healthcare sector, most recently as a member of the healthcare management consultancy McKinsey & Company, where he helped develop the McKinsey Hospital Institute in the UK.

Declaration of interests:

  • Former employee, McKinsey & Company.
  • Director, MY UCLH
  • Member, NHS Staff College Board

back to top


Dr Charles House

Dr Charles House, medical director, medicine board

Charles House was appointed Medical Director in July 2017 having previously been the interim Medical Director since March 2016. He studied medicine at St Mary’s Hospital Medical School and trained in radiology at UCLH, being appointed here as consultant radiologist in 2005, with subspecialist interests in bone and soft tissue sarcoma, myeloma and orthopaedic imaging. After spells as College Tutor for the UCLH radiology training scheme and clinical lead in radiology, Charles had previously held posts as Divisional Clinical Director of Imaging and Associate Medical Director. Charles has a keen interest in clinical leadership and evolving models of healthcare, with focus on collaboration between organisations and across sectors.
 
Charles has a keen interest in clinical leadership and evolving models of healthcare, with focus on collaboration between organisations and across sectors.
 
Declaration of interests:
  • Non-executive Director, Radiology reporting Online

back to top


Tim Jaggard

Tim Jaggard, finance director

Tim Jaggard was appointed Finance Director in April 2016 having previously held the posts of Interim Finance Director and Deputy Finance Director at UCLH. He joined from the Whittington in 2010 where he was Deputy Finance Director for two years. Prior to this Tim held senior finance positions in service line reporting, patient level costing, commissioning and financial management. He graduated from the NHS graduate training scheme in 2006. He has a degree in Psychology from Cambridge which was followed by further study at the Judge Business School.
 
Declaration of interests:
  • No interests to declare

back to top


Professor Tony Mundy

Professor Tony Mundy, corporate medical director

Tony Mundy has been a Medical Director since 2001. Since November 2006 he has been the Corporate Medical Director with UCLH-wide responsibility for quality and safety and for research and development. He is the UCLH responsible officer for the revalidation of doctors under the GMC registration regulations. He was previously Clinical Director of Urology and Nephrology and then Medical Director for Medicine and Surgery from 2001 to 2006. Tony is a professor of urology at the University of London and Director of the Institute of Urology.

Declaration of Interests:

  • No interests to declare.

back to top


Flo Panel-Coates

Flo Panel-Coates, chief nurse

FFlo Panel-Coates was appointed UCLH Chief Nurse in April 2015, coming to the organisation from Barking, Havering and Redbridge University NHS Trust where she was Chief Nurse for two and a half years. Prior to that she was Director of Nursing and Quality at Maidstone and Tunbridge Wells NHS Trust from August 2008 until September 2012. She also held positions of Director of Nursing and Midwifery, and Director of Infection Prevention and Control at the North Middlesex University Hospital NHS Trust from September 2005 to August 2008. She has a keen interest in organisational culture and in creating different ways of working to release more time to care.
 
Declaration of Interests:
  • Non-executive director of NHS Innovations South East, since January 2012, and chair of its finance committee
  • Invited Member, London Leadership Academy Reference Group
  • Member (and Chair from August 2015), The Executive Nursing Network

back to top


Other directors who attend the Board
Mr Ben Morrin

Ben Morrin, Director of Workforce

Ben Morrin joined UCLH as the Director of Workforce in September 2014. In the preceding decade he worked across the Department of Health and within the Prime Minister’s Delivery Unit. Ben is a Fellow of the Chartered Institute for Personnel and Development.
 
Declaration of Interests:
 
  • Wife is a civil servant employed at the Department of Health and Trustee of Cruse

back to top